Frank Murphy

Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada.

Part of Takeda Pharmaceutical Co., Ltd., Takeda Canada, Inc. is a biopharmaceutical company based in Mississauga, CA. Takeda provides financial data for investors and is focused on developing innovative medicines to make a difference in people's lives. The Canadian company is committed to discovering and delivering life-transforming treatments in the areas of oncology, rare genetics and hematology, neuroscience, and gastroenterology. Takeda also invests in plasma-derived therapies and vaccines. The company's employees are dedicated to improving the quality of life for patients and working with healthcare partners in approximately 80 countries and regions.